2-Bromo-5-methylthiazole - CAS 41731-23-1
Catalog: |
BB024942 |
Product Name: |
2-Bromo-5-methylthiazole |
CAS: |
41731-23-1 |
Synonyms: |
2-bromo-5-methylthiazole; 2-bromo-5-methyl-1,3-thiazole |
IUPAC Name: | 2-bromo-5-methyl-1,3-thiazole |
Description: | 2-Bromo-5-methylthiazole (CAS# 41731-23-1) is a useful research chemical used in the preparation of (thiazolylalkyl)sulfoximine derivatives. and insecticidal activity against Myzus persicae. |
Molecular Weight: | 178.05 |
Molecular Formula: | C4H4BrNS |
Canonical SMILES: | CC1=CN=C(S1)Br |
InChI: | InChI=1S/C4H4BrNS/c1-3-2-6-4(5)7-3/h2H,1H3 |
InChI Key: | FJPZHYAYNAUKKA-UHFFFAOYSA-N |
Boiling Point: | 192-200 °C |
Density: | 1.702 g/cm3 |
MDL: | MFCD08460610 |
LogP: | 2.21400 |
GHS Hazard Statement: | H302 (66.67%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
KR-102178181-B1 | Novel hydrazone derivatives comprising aryl or heteroaryl group substituted at terminal amine and use thereof | 20200331 |
KR-20200076655-A | Novel hydrazone derivatives comprising aryl or heteroaryl group substituted at terminal amine and use thereof | 20200331 |
KR-102293986-B1 | Isoquinolinone derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating poly(ADP-ribose)polymerase-1 related diseases containg the same as an active ingredient | 20191030 |
KR-20210052330-A | Isoquinolinone derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating poly(ADP-ribose)polymerase-1 related diseases containg the same as an active ingredient | 20191030 |
WO-2021086077-A1 | Isoquinolinone derivative, preparation method therefor, and pharmaceutical composition, comprising same as active ingredient, for prevention or treatment of poly(adp-ribose)polymerase-1 (parp-1)-associated disease | 20191030 |
Complexity: | 68.7 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 176.92478 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 176.92478 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 41.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Oxazole/Thiazole
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS